ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,341, issued on Dec. 16, was assigned to HTYR Acquisition LLC (Philadelphia).
"Methods for reducing anergy in lymphocytes using modulators of MYC" was invented by Yosef Refaeli (Denver) and Brian Curtis Turner (Denver).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of modulation of the viability of a cell. Further disclosed herein are methods of modulating an immune response. Further disclosed herein are methods of identifying agents capable of modulation of the viability of a cell or an immune response. Further disclosed herein are agents and compositions capable of modulation of the viability of a cell or an immune respo...